-+ 0.00%
-+ 0.00%
-+ 0.00%

IDEXX Laboratories acquires veterinary AI scribe platform CoVetAI

PUBT·09/30/2026 13:05:18
Listen to the news
IDEXX Laboratories acquires veterinary AI scribe platform CoVetAI
  • IDEXX Laboratories agreed to acquire CoVetAI, an AI-powered clinical scribe and workflow platform for veterinary medicine.
  • Financial terms were not disclosed.
  • Chicago Pacific Founders’ Pet Fund exited its investment in CoVetAI as part of the deal.
  • The acquisition expands IDEXX’s footprint in veterinary practice software, reinforcing demand for AI-enabled clinical tools.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IDEXX Laboratories Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: CG59903) on September 30, 2026, and is solely responsible for the information contained therein.